Skip to main content
HE

HemoGenyx

London, United Kingdom
Last funding
$393K
Post-IPO EquitySep 2026

New treatment for blood diseases, such as leukemia and lymphoma.

Backed byPrevail Partners43NorthScaleReadyMint Capital

About HemoGenyx

How much funding has HemoGenyx raised?

HemoGenyx has raised $393K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2026.

Who are HemoGenyx's investors?

HemoGenyx's investors include Prevail Partners, 43North, ScaleReady, Mint Capital.

Where is HemoGenyx headquartered?

HemoGenyx is headquartered in London, United Kingdom.

What does HemoGenyx do?

New treatment for blood diseases, such as leukemia and lymphoma.

What stage is HemoGenyx at?

HemoGenyx is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"HemoGenyx — Funding & Investors." VCBacked, September 3, 2026, https://www.vcbacked.co/company/hemogenyx. Accessed November 14, 2026.
APA
VCBacked. (2026). HemoGenyx — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/hemogenyx
Wikipedia (cite web)
{{cite web |title=HemoGenyx — Funding & Investors |url=https://www.vcbacked.co/company/hemogenyx |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at HemoGenyx? Request a listing update

Founder contacts
m***@hemogenyx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →